Clinical Trial Update: Omega-3 Fatty Acids in Sickle Cell Disease [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on omega-3 fatty acids in sickle cell disease has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Robin E. Miller | Conditions: Sickle Cell Disease | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-10-19